BBI Solutions launch of cutting edge, sensitivity enhancing technologies at Medica 2013
10/28/2013

New and unique sensitivity enhancing technology for assay development will be launched by BBI Solutions at Medica 2013, alongside detailed information on its portfolio of critical reagents and contract manufacturing services.

Online PR News – 28-October-2013 – Cardiff, UK – BBI Solutions will be launching new and unique sensitivity enhancing technology in Hall 1, Booth F24 at Medica 2013, alongside detailed information on its portfolio of critical reagents and contract manufacturing services. Specialists from BBI Solutions, formed by the merger of four of its well-known and established core business entities BBInternational, BBI Enzymes, Scipac and Vision Biotech, will also be engaging with customers and giving new, live on-booth presentations throughout the show.

Once again leading the way in assay development, BBI Solutions has arranged a series of technical presentations and demonstrations that will highlight how its innovative technology can enable manufacturers to produce more accurate and reliable clinical assays. On each day, information will be presented on the Novarum mobile technology and how it can revolutionize Lateral Flow assays, particularly their use as part of a drive towards ‘connected healthcare’. Day Two sees the launch of the new enhanced sensitivity technology that includes signal enhancement. A presentation will be given on BBI Solutions’ Booth F1 at 11.30am and full details will be revealed. On Day 3, BBI Solutions will show how its new latest generation of recombinant Fab monoclonal antibodies can enhance assay performance. Attendees are able to guarantee their places for all these presentations by registering their interest here http://www.bbisolutions.com/events

Visitors to the show will also have the opportunity to discover all that BBI Solutions has to offer the global diagnostic and healthcare markets. The product range includes a comprehensive range of antibodies, proteins, disease state plasma, enzymes and nanoparticles, while experts will be on hand to discuss BBI Solutions’ expertise in contract manufacturing of assays and raw materials along with assay development services.

- ends -

Enquiries:
Carly Unsworth
BBI Solutions
Tel: +44 (0) 2920 747232
E-mail: carlyunsworth@bbisolutions.com
www.bbisolutions.com

UK Press Contact:
Eileen Holmes-Ievers.
In Press Public Relations Ltd.
Tel: +44 (0)1488 674200 Mob: 07774 968272
E-mail: eileen@inpress.co.uk
Twitter: twitter.com/InPressPR

112BBI
October 28, 2013